Justin BekelmanCo Founder

United States - Philadelphia, Pennsylvania

Dr. Justin Bekelman is an internationally recognized oncologist and innovator who has devoted his career to improving the health and lives of patients with cancer. He is the co-founder and CEO of Daymark Health, a value-based oncology company redefining the cancer care experience for patients, providers, and health plans. Dr. Bekelman was inspired to start Daymark because he believes there is a better way to help patients access world-class, compassionate cancer care and to work with oncologists, health plans, and hospitals to change the system from within.

Throughout his 20-year career in oncology, Dr. Bekelman has made seminal discoveries that have changed the practice of cancer care. He has authored nearly 200 research articles and spearheaded large-scale research programs funded by the U.S. National Cancer Institute and the Patient Centered Outcomes Research Institute. Dr. Bekelman previously led Penn Medicine’s Center for Cancer Care Innovation at the Abramson Cancer Center and continues to see patients at the University of Pennsylvania School of Medicine. He also served as Special Assistant to the Under Secretary of Defense in the U.S. Department of Defense.